{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:11:37Z","timestamp":1785510697133,"version":"3.56.0"},"reference-count":70,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["514798"],"award-info":[{"award-number":["514798"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["RN419944\u2010439999"],"award-info":[{"award-number":["RN419944\u2010439999"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["RN455800\u2010465038"],"award-info":[{"award-number":["RN455800\u2010465038"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["466984"],"award-info":[{"award-number":["466984"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["480413"],"award-info":[{"award-number":["480413"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016197","name":"Leslie Dan Faculty of Pharmacy, University of Toronto","doi-asserted-by":"publisher","award":["511794"],"award-info":[{"award-number":["511794"]}],"id":[{"id":"10.13039\/501100016197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031019","name":"Digital Technology Supercluster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>Understanding how COVID\u201019 impacts the expression of clinically relevant drug metabolizing enzymes and membrane transporters (DMETs) is vital for addressing potential safety and efficacy concerns related to systemic and peripheral drug concentrations. This study investigates the impact of COVID\u201019 severity on DMETs expression and the underlying mechanisms to inform the design of precise clinical dosing regimens for affected patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Transcriptomics analysis of 102 DMETs, 10 inflammatory markers, and 12 xenosensing regulatory genes was conducted on nasopharyngeal swabs from 50 SARS\u2010CoV\u20102 positive (17 outpatients, 16 non\u2010ICU, and 17 ICU) and 13 SARS\u2010CoV\u20102 negative individuals, clinically tested through qPCR, in the Greater Toronto area from October 2020 to October 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We observed a significant differential gene expression for 42 DMETs, 6 inflammatory markers, and 9 xenosensing regulatory genes. COVID\u201019 severity was associated with the upregulation of <jats:italic>AKR1C1<\/jats:italic>, <jats:italic>MGST1<\/jats:italic>, and <jats:italic>SULT1E1<\/jats:italic>, and downregulation of <jats:italic>ABCC10<\/jats:italic>, <jats:italic>CYP3A43<\/jats:italic>, and <jats:italic>SLC29A4<\/jats:italic> expressions. Altogether, SARS\u2010CoV\u20102\u2010positive patients showed an upregulation in <jats:italic>CYP2C9<\/jats:italic>, <jats:italic>CYP2C19<\/jats:italic>, <jats:italic>AKR1C1<\/jats:italic>, <jats:italic>SULT1B1<\/jats:italic>, <jats:italic>SULT2B1<\/jats:italic>, and <jats:italic>SLCO4A1<\/jats:italic> and downregulation in <jats:italic>FMO5<\/jats:italic>, <jats:italic>MGST3<\/jats:italic>, <jats:italic>ABCC5<\/jats:italic>, and <jats:italic>SLCO4C1<\/jats:italic> compared with SARS\u2010CoV\u20102 negative individuals. These dysregulations were associated with significant changes in the expression of inflammatory and xenosensing regulatory genes driven by the disease. <jats:italic>GSTM3<\/jats:italic>, <jats:italic>PPARA<\/jats:italic>, and <jats:italic>AKR1C1<\/jats:italic> are potential biomarkers of the observed DMETs dysregulation pattern in nasopharyngeal swabs of outpatients, non\u2010ICU, and ICU patients, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The severity of COVID\u201019 is associated with the dysregulation of DMETs involved in processing commonly prescribed drugs, suggesting potential disease\u2013drug interactions, especially for narrow therapeutic index drugs.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.16124","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T07:31:02Z","timestamp":1717140662000},"page":"2137-2158","source":"Crossref","is-referenced-by-count":5,"title":["COVID\u201019 severity gradient differentially dysregulates clinically relevant drug processing genes in nasopharyngeal swab samples"],"prefix":"10.1111","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1889-0334","authenticated-orcid":false,"given":"Chukwunonso K.","family":"Nwabufo","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy University of Toronto  Toronto ON Canada"},{"name":"Program in Translational Medicine Hospital for Sick Children  Toronto ON Canada"},{"name":"OneDrug Inc.  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Luc","sequence":"additional","affiliation":[{"name":"Department of Biology and Waterloo Centre for Microbial Research University of Waterloo  Waterloo ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"McGeer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases University of Toronto  Toronto Ontario Canada"},{"name":"Mount Sinai Hospital  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Alexander","family":"Hirota","sequence":"additional","affiliation":[{"name":"Department of Biology and Waterloo Centre for Microbial Research University of Waterloo  Waterloo ON Canada"},{"name":"Department of Medicine McMaster University  Hamilton ON Canada"},{"name":"Firestone Institute for Respiratory Health\u2014Division of Respirology, Department of Medicine McMaster University  Hamilton ON Canada"},{"name":"Research Institute of St. Joe's Hamilton  Hamilton ON Canada"},{"name":"Division of Respiratory Medicine, Department of Medicine University of British Columbia  Vancouver British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Mubareka","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute  Toronto ON Canada"},{"name":"Department of Laboratory Medicine and Pathobiology University of Toronto  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Doxey","sequence":"additional","affiliation":[{"name":"Department of Biology and Waterloo Centre for Microbial Research University of Waterloo  Waterloo ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo J.","family":"Moraes","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy University of Toronto  Toronto ON Canada"},{"name":"Program in Translational Medicine Hospital for Sick Children  Toronto ON Canada"},{"name":"Department of Pediatrics Hospital for Sick Children  Toronto ON Canada"},{"name":"Department of Pediatrics University of Toronto  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"e_1_2_11_2_1","volume-title":"Emergency committee on the COVID\u201019 pandemic","author":"World Health Organization","year":"2005"},{"key":"e_1_2_11_3_1","volume-title":"WHO coronavirus (COVID\u201019) dashboard","author":"World Health organization"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010022\u201002185\u20104"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010023\u201002219\u20105"},{"key":"e_1_2_11_6_1","first-page":"1","volume-title":"StatPearls","author":"Cascella M","year":"2022"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfda.2018.11.005"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2432"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107627"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01648"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25948"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14668"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586\u2010021\u201003475\u20106"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12024\u2010021\u201000414\u20109"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2022.09.005"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200223666220621113524"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa195"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14193"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2698"},{"key":"e_1_2_11_20_1","volume-title":"COVID\u201019 treatment guidelines","author":"National Institutes of Health"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2021.1908262"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122042"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab578"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMvcm2010260"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108319"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978\u20100\u201012\u2010814974\u20104.00004\u20103"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13780"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1124693"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13059\u2010014\u20100550\u20108"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty560"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4197"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1087"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16181"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16182"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16179"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16180"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200217666160406120509"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.005769"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0027\u20105107(97)00127\u20109"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.3109\/10408449109019571"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.3109\/03602539308993975"},{"issue":"1","key":"e_1_2_11_42_1","first-page":"1","article-title":"In vitro drug interaction studies \u2010 Cytochrome P450 enzyme and transporter mediated drug interactions","volume":"1","author":"US Food and Drug Administration","year":"2020","journal-title":"FDA Guid"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2022.7762"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1071"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.07.015"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040688"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.0c00288"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27076"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.05.041"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12030458"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.747493"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127358"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13718"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110197"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.020"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v32.i1.30"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1161067"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm8003575"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2010.10.006"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12473"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M006655200"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012\u20100457OC"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2020.1858234"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1124\/molpharm.121.000333"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1124\/molpharm.121.000448"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1124\/molpharm.121.000425"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2236"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2646"},{"key":"e_1_2_11_69_1","volume-title":"FDA approves first Oral antiviral for treatment of COVID\u201019 in adults","author":"US Food and Drug Administration"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280\u2010023\u201004575\u2010y"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11830"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.16124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T08:08:30Z","timestamp":1724918910000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.16124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1111\/bcp.16124"],"URL":"https:\/\/doi.org\/10.1111\/bcp.16124","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}